Von Willebrand factor propeptide compared to von Willebrand factor as plasma marker of endothelial activation in systemic sclerosis.

被引：0
|
作者：
Scheja, A
Wildt, M
Wollheim, F
Akesson, A
Vischer, U
机构：
来源：
ARTHRITIS AND RHEUMATISM | 1999年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
820
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [31] Genome-wide studies of von Willebrand factor propeptide identify loci contributing to variation in propeptide levels and von Willebrand factor clearance
    Ozel, A. B.
    McGee, B.
    Siemieniak, D.
    Jacobi, P. M.
    Haberichter, S. L.
    Brody, L. C.
    Mills, J. L.
    Molloy, A. M.
    Ginsburg, D.
    Li, J. Z.
    Desch, K. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (09) : 1888 - 1898
  • [32] Characterization of a novel mutation in the von Willebrand factor propeptide in a distinct subtype of recessive von Willebrand disease
    Lanke, Elsa
    Kristoffersson, Ann-Charlotte
    Philips, Malou
    Holmberg, Lars
    Lethagen, Stefan
    THROMBOSIS AND HAEMOSTASIS, 2008, 100 (02) : 211 - 216
  • [33] von Willebrand disease phenotype and von Willebrand factor marker genotype in Doberman Pinschers
    Brooks, MB
    Erb, HN
    Foureman, PA
    Ray, K
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2001, 62 (03) : 364 - 369
  • [34] Von Willebrand factor and von Willebrand disease - Preface
    Michiels, JJ
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (02) : VII - VII
  • [35] von Willebrand Factor Antigen, von Willebrand Factor Propeptide, and ADAMTS13 in Carotid Stenosis and Their Relationship with Cerebral Microemboli
    Murphy, Stephen J. X.
    Lim, Soon Tjin
    Hickey, Fionnuala
    Kinsella, Justin A.
    Smith, Deirdre R.
    Tierney, Sean
    Egan, Bridget
    Feeley, T. Martin
    Murphy, Sinead M.
    Collins, D. Ronan
    Coughlan, Tara
    O'Neill, Desmond
    Harbison, Joseph A.
    Madhavan, Prakash
    O'Neill, Sean M.
    Colgan, Mary-Paula
    O'Donnell, James S.
    O'Sullivan, Jamie M.
    Hamilton, George
    McCabe, Dominick J. H.
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (01) : 86 - 97
  • [36] The Use of Phage Display and Yeast Based Expression System for the Development of a Von Willebrand Factor Propeptide Assay: Development of a Von Willebrand Factor Propeptide Assay
    Meiring, S. M.
    Setlai, B. D. P.
    Theron, C.
    Bragg, R.
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [37] Profile of von Willebrand factor antigen and von Willebrand factor propeptide in an overall TIA and ischaemic stroke population and amongst subtypes
    Tobin, W. O.
    Kinsella, J. A.
    Kavanagh, G. F.
    O'Donnell, J. S.
    McGrath, R. T.
    Tierney, S.
    Egan, B.
    Feeley, T. M.
    Coughlan, T.
    Collins, D. R.
    O'Neill, D.
    Murphy, S. J. X.
    Lim, S. J.
    Murphy, R. P.
    McCabe, D. J. H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 375 : 404 - 410
  • [38] Elevated Plasma Von Willebrand Factor and Propeptide Levels in Malawian Children with Malaria
    Phiri, Happy T.
    Bridges, Daniel J.
    Glover, Simon J.
    van Mourik, Jan A.
    de Laat, Bas
    M'baya, Bridon
    Taylor, Terrie E.
    Seydel, Karl B.
    Molyneux, Malcolm E.
    Faragher, E. Brian
    Craig, Alister G.
    Bunn, James E. G.
    PLOS ONE, 2011, 6 (11):
  • [39] VON WILLEBRAND FACTOR - A MARKER FOR HEPATOPULMONARY SYNDROME
    Horvatits, T.
    Drolz, A.
    Ferlitsch, A.
    Mueller, C.
    Schenk, P.
    Fuhrmann, V.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S88 - S88
  • [40] Von Willebrand factor a marker for hepatopulmonary syndrome
    Horvatits, T.
    Drolz, A.
    Ferlitsch, A.
    Schenk, P.
    Mueller, C.
    Fuhrmann, V.
    WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (19-20) : 652 - 652
12345